Park Ha Biological Technology Co., Ltd. cash flow statement

In fiscal 2025, Park Ha Biological Technology Co., Ltd.'s operations generated $85,852 of cash; it spent $88,825 on capital projects, leaving free cash flow of −$2,973.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Park Ha Biological Technology Co., Ltd.: cash flow statement, annual
Fiscal year	2022Oct 2022	2023Oct 2023	2024Oct 2024	2025Oct 2025
Cash from operations	1	0	1	0
Depreciation and amortisation	0	0	0	0
Stock-based pay	—	—	—	24
Capital spending	0	0	0	0
Free cash flow	1	0	1	−0
Free cash flow after stock pay	—	—	—	−24
Shares issued	—	—	—	4

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: BYAH vs SNES BYAH vs ZONE BYAH vs CITR BYAH vs REFR

More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies

Figures from Park Ha Biological Technology Co., Ltd.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Park Ha Biological Technology Co., Ltd.